1h Free Analyst Time
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. The publisher has been monitoring the rapid plasma reagin test market and it is poised to grow by $ 46.28 mn during 2022-2026 progressing at a CAGR of 4.26% during the forecast period. The report on rapid plasma reagin test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of syphilis, the adoption of serological tests by blood banks, and the rising uptake of RPR in antenatal clinics (ANCs).
The rapid plasma reagin test market analysis includes test segment and geographic landscape.
The rapid plasma reagin test market is segmented as below:
By Test
- Rapid plasma reagin test kits
- Analyzers and instruments
- Reagents
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the automated RPR systems as one of the prime reasons driving the rapid plasma reagin test market growth during the next few years. Also, automated RPR systems, growing number of healthcare testing programs and awareness programs for sexually transmitted diseases, and technological advancements in RPR testing will lead to sizable demand in the market.
By the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The report on the rapid plasma reagin test market covers the following areas:
- Rapid plasma reagin test market sizing
- Rapid plasma reagin test market forecast
- Rapid plasma reagin test market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rapid plasma reagin test market vendors that include Abbott Laboratories, Anamol Laboratories Pvt. Ltd., ARKRAY Inc., Arlington Scientific Inc., Atlas Medical GmbH, Becton Dickinson and Co., Bio Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann La Roche Ltd., Innovatek Medical Inc., Lorne Laboratories Ltd., Mediclone Biotech, Newmarket Biomedical Ltd., Novacyt SA, Sclavo Diagnostics International S.r.l., Sekisui Chemical Co. Ltd., and Thermo Fisher Scientific Inc. Also, the rapid plasma reagin test market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Test
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Exhibits:
Executive Summary
The Publisher Announces the Publication of its Research Report - Global Rapid Plasma Reagin Test Market 2022-2026The publisher recognizes the following companies as the key players in the global rapid plasma reagin test market: Abbott Laboratories, Anamol Laboratories Pvt. Ltd., ARKRAY Inc., Arlington Scientific Inc., Atlas Medical GmbH, Becton Dickinson and Co., Bio Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann La Roche Ltd., Innovatek Medical Inc., Lorne Laboratories Ltd., Mediclone Biotech, Newmarket Biomedical Ltd., Novacyt SA, Sclavo Diagnostics International S.r.l., Sekisui Chemical Co. Ltd., and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is automated RPR systems.'
According to the report, one of the major drivers for this market is the increasing incidence of syphilis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Anamol Laboratories Pvt. Ltd.
- ARKRAY Inc.
- Arlington Scientific Inc.
- Atlas Medical GmbH
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Cardinal Health Inc.
- F. Hoffmann La Roche Ltd.
- Innovatek Medical Inc.
- Lorne Laboratories Ltd.
- Mediclone Biotech
- Newmarket Biomedical Ltd.
- Novacyt SA
- Sclavo Diagnostics International S.r.l.
- Sekisui Chemical Co. Ltd.
- Thermo Fisher Scientific Inc.
